Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.24 USD | +0.32% | -21.01% | -29.49% |
10/05 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
07/05 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.49% | 5.3M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Ladenburg Thalmann Adjusts Price Target on Palisade Bio to $16 From $25, Maintains Buy Rating